Organization
R-Pharm
9 clinical trials
Clinical trial
International, Multicenter, Double-blind, Randomized, Comparative Study of Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin MelanomaStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Multicenter, Open-label, Randomized Study of the Efficacy and Safety of Artlegia (INN: Olokizumab) New Dosing Regimen in Patients With Coronavirus Infection (COVID-19) With Signs of HyperinflammationStatus: Active (not recruiting), Estimated PCD: 2022-10-31
Clinical trial
International, Multicenter, Double-blind, Randomized, Comparative Study of the Pharmacokinetics, Safety and Efficacy of RPH-075 and Keytruda® in Patients With Malignant NeoplasmsStatus: Active (not recruiting), Estimated PCD: 2023-12-11
Clinical trial
Randomized Open-label Multicenter Parallel-group Study of Efficacy and Safety of TL-FVP-t vs. Standard of Care Therapy in Patients With Mild to Moderate Coronavirus Disease (SARS-CoV-2/COVID-19)Status: Completed, Estimated PCD: 2020-07-29
Clinical trial
An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic® in Adult Patients With Community-acquired PneumoniaStatus: Completed, Estimated PCD: 2017-12-13
Clinical trial
Multicentre Non-interventional Retrospective Cohort Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) InfectionStatus: Completed, Estimated PCD: 2022-08-29
Clinical trial
A Phase I/II Single-Blinded Randomised Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of COVID-19Status: Completed, Estimated PCD: 2022-03-29
Clinical trial
Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1Status: Completed, Estimated PCD: 2020-04-08
Clinical trial
Retrospective Registry for the Efficacy and Safety Evaluation of Refralon®, Concentrate for Solution for Intravenous Injection in Patients With Paroxysmal and Persistent Atrial Fibrillation and FlutterStatus: Completed, Estimated PCD: 2023-06-01